dalteparin has been researched along with Bowel Diseases, Inflammatory in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Colitis was induced by acetic acid (AA)." | 5.38 | Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. ( Aygun, C; Bahcecioglu, IH; Demirel, U; Orhan, C; Ozercan, IH; Sahin, K; Tuzcu, M; Yalniz, M, 2012) |
| "Colitis was induced by acetic acid (AA)." | 1.38 | Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. ( Aygun, C; Bahcecioglu, IH; Demirel, U; Orhan, C; Ozercan, IH; Sahin, K; Tuzcu, M; Yalniz, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yalniz, M | 1 |
| Demirel, U | 1 |
| Orhan, C | 1 |
| Bahcecioglu, IH | 1 |
| Ozercan, IH | 1 |
| Aygun, C | 1 |
| Tuzcu, M | 1 |
| Sahin, K | 1 |
| Leeds, IL | 1 |
| Sklow, B | 1 |
| Gorgun, E | 1 |
| Liska, D | 1 |
| Lightner, AL | 1 |
| Hull, TL | 1 |
| Steele, SR | 1 |
| Holubar, SD | 1 |
| Sbeit, W | 1 |
| Kadah, A | 1 |
| Shafrir, A | 1 |
| Kalisky, I | 1 |
| Mahamid, M | 1 |
| Hazou, W | 1 |
| Katz, L | 1 |
| Mari, A | 1 |
| Khoury, T | 1 |
| Diamond, CE | 1 |
| Hennessey, C | 1 |
| Meldau, J | 1 |
| Guelcher, CJ | 1 |
| Guerrera, MF | 1 |
| Conklin, LS | 1 |
| Sharma, KV | 1 |
| Diab, YA | 1 |
| O'Flynn, AM | 1 |
| Watts, M | 1 |
| Wall, D | 1 |
| Molefe, C | 1 |
| O'Keeffe, D | 1 |
| Finucane, P | 1 |
5 other studies available for dalteparin and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats.
Topics: Acetic Acid; Animals; Colitis; Colon; Cyclooxygenase 2; Heme Oxygenase-1; Inflammatory Bowel Disease | 2012 |
Cost-Effectiveness of Aspirin for Extended Venous Thromboembolism Prophylaxis After Major Surgery for Inflammatory Bowel Disease.
Topics: Aftercare; Anticoagulants; Aspirin; Cost-Benefit Analysis; Enoxaparin; Humans; Inflammatory Bowel Di | 2022 |
Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Awareness; Colitis | 2020 |
Catheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thromboprophylaxis with Enoxaparin.
Topics: Adolescent; Anticoagulants; Catheterization, Central Venous; Central Venous Catheters; Child; Enoxap | 2018 |
Inflammatory bowel disease and thromboembolism. Is inflammation at the centre of the clot?
Topics: Adult; Anticoagulants; Female; Heparin, Low-Molecular-Weight; Humans; Inflammation; Inflammatory Bow | 2013 |